135 related articles for article (PubMed ID: 15213225)
1. Mapping of the leptin binding sites and design of a leptin antagonist.
Peelman F; Van Beneden K; Zabeau L; Iserentant H; Ulrichts P; Defeau D; Verhee A; Catteeuw D; Elewaut D; Tavernier J
J Biol Chem; 2004 Sep; 279(39):41038-46. PubMed ID: 15213225
[TBL] [Abstract][Full Text] [Related]
2. Mapping of binding site III in the leptin receptor and modeling of a hexameric leptin.leptin receptor complex.
Peelman F; Iserentant H; De Smet AS; Vandekerckhove J; Zabeau L; Tavernier J
J Biol Chem; 2006 Jun; 281(22):15496-504. PubMed ID: 16540470
[TBL] [Abstract][Full Text] [Related]
3. Leptin receptor activation depends on critical cysteine residues in its fibronectin type III subdomains.
Zabeau L; Defeau D; Iserentant H; Vandekerckhove J; Peelman F; Tavernier J
J Biol Chem; 2005 Jun; 280(24):22632-40. PubMed ID: 15840566
[TBL] [Abstract][Full Text] [Related]
4. Mapping of the interface between leptin and the leptin receptor CRH2 domain.
Iserentant H; Peelman F; Defeau D; Vandekerckhove J; Zabeau L; Tavernier J
J Cell Sci; 2005 Jun; 118(Pt 11):2519-27. PubMed ID: 15923664
[TBL] [Abstract][Full Text] [Related]
5. Identification of the hydrophobic strand in the A-B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists.
Niv-Spector L; Gonen-Berger D; Gourdou I; Biener E; Gussakovsky EE; Benomar Y; Ramanujan KV; Taouis M; Herman B; Callebaut I; Djiane J; Gertler A
Biochem J; 2005 Oct; 391(Pt 2):221-30. PubMed ID: 15952938
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of naturally occurring pathogenic mutations in the human leptin receptor.
Kimber W; Peelman F; Prieur X; Wangensteen T; O'Rahilly S; Tavernier J; Farooqi IS
Endocrinology; 2008 Dec; 149(12):6043-52. PubMed ID: 18703626
[TBL] [Abstract][Full Text] [Related]
7. Selection of non-competitive leptin antagonists using a random nanobody-based approach.
Zabeau L; Verhee A; Catteeuw D; Faes L; Seeuws S; Decruy T; Elewaut D; Peelman F; Tavernier J
Biochem J; 2012 Jan; 441(1):425-34. PubMed ID: 21851341
[TBL] [Abstract][Full Text] [Related]
8. Mapping leptin-interacting sites in recombinant leptin-binding domain (LBD) subcloned from chicken leptin receptor.
Niv-Spector L; Raver N; Friedman-Einat M; Grosclaude J; Gussakovsky EE; Livnah O; Gertler A
Biochem J; 2005 Sep; 390(Pt 2):475-84. PubMed ID: 15842201
[TBL] [Abstract][Full Text] [Related]
9. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits.
Presky DH; Yang H; Minetti LJ; Chua AO; Nabavi N; Wu CY; Gately MK; Gubler U
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14002-7. PubMed ID: 8943050
[TBL] [Abstract][Full Text] [Related]
10. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
11. 20 years of leptin: insights into signaling assemblies of the leptin receptor.
Peelman F; Zabeau L; Moharana K; Savvides SN; Tavernier J
J Endocrinol; 2014 Oct; 223(1):T9-23. PubMed ID: 25063754
[TBL] [Abstract][Full Text] [Related]
12. The Ig-like domain of human GM-CSF receptor alpha plays a critical role in cytokine binding and receptor activation.
Mirza S; Walker A; Chen J; Murphy JM; Young IG
Biochem J; 2010 Feb; 426(3):307-17. PubMed ID: 20078425
[TBL] [Abstract][Full Text] [Related]
13. A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling.
Yang RB; Ng CK; Wasserman SM; Kömüves LG; Gerritsen ME; Topper JN
J Biol Chem; 2003 Aug; 278(35):33232-8. PubMed ID: 12807873
[TBL] [Abstract][Full Text] [Related]
14. Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.
Tavernier J; Tuypens T; Verhee A; Plaetinck G; Devos R; Van der Heyden J; Guisez Y; Oefner C
Proc Natl Acad Sci U S A; 1995 May; 92(11):5194-8. PubMed ID: 7761472
[TBL] [Abstract][Full Text] [Related]
15. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
16. Homology modeling of human leptin/leptin receptor complex.
Hiroike T; Higo J; Jingami H; Toh H
Biochem Biophys Res Commun; 2000 Aug; 275(1):154-8. PubMed ID: 10944457
[TBL] [Abstract][Full Text] [Related]
17. Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin.
McWherter CA; Feng Y; Zurfluh LL; Klein BK; Baganoff MP; Polazzi JO; Hood WF; Paik K; Abegg AL; Grabbe ES; Shieh JJ; Donnelly AM; McKearn JP
Biochemistry; 1999 Apr; 38(14):4564-71. PubMed ID: 10194378
[TBL] [Abstract][Full Text] [Related]
18. Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site.
Miedlich SU; Gama L; Seuwen K; Wolf RM; Breitwieser GE
J Biol Chem; 2004 Feb; 279(8):7254-63. PubMed ID: 14660633
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of a mutation in PAX9 associated with familial tooth agenesis in humans.
Mensah JK; Ogawa T; Kapadia H; Cavender AC; D'Souza RN
J Biol Chem; 2004 Feb; 279(7):5924-33. PubMed ID: 14607846
[TBL] [Abstract][Full Text] [Related]
20. Crucial role of the residue R280 at the F'-G' loop of the human granulocyte/macrophage colony-stimulating factor receptor alpha chain for ligand recognition.
Rajotte D; Cadieux C; Haman A; Wilkes BC; Clark SC; Hercus T; Woodcock JA; Lopez A; Hoang T
J Exp Med; 1997 Jun; 185(11):1939-50. PubMed ID: 9166423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
